Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$4.35 - $5.76 $5,237 - $6,935
-1,204 Reduced 14.18%
7,288 $0
Q1 2022

May 16, 2022

SELL
$3.92 - $6.25 $2,732 - $4,356
-697 Reduced 7.59%
8,492 $46,000
Q4 2021

Feb 08, 2022

BUY
$5.52 - $8.42 $50,723 - $77,371
9,189 New
9,189 $52,000

About PolyPid Ltd.


  • Ticker PYPD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,551,200
  • Market Cap $69.6M
  • Description
  • PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well a...
More about PYPD
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.